- Home
- SDOT vs CARM Comparison
SDOT vs CARM Comparison
Compare SDOT & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- CARM
- Stock Information
- Founded
- SDOT 2014
- CARM 2016
- Country
- SDOT United States
- CARM United States
- Employees
- SDOT N/A
- CARM N/A
- Industry
- SDOT Restaurants
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- CARM Health Care
- Exchange
- SDOT Nasdaq
- CARM Nasdaq
- Market Cap
- SDOT 8.0M
- CARM 8.4M
- IPO Year
- SDOT 2020
- CARM N/A
- Fundamental
- Price
- SDOT $1.41
- CARM $0.42
- Analyst Decision
- SDOT
- CARM Hold
- Analyst Count
- SDOT 0
- CARM 5
- Target Price
- SDOT N/A
- CARM $0.90
- AVG Volume (30 Days)
- SDOT 566.5K
- CARM 42.1M
- Earning Date
- SDOT 08-12-2025
- CARM 08-07-2025
- Dividend Yield
- SDOT N/A
- CARM N/A
- EPS Growth
- SDOT N/A
- CARM N/A
- EPS
- SDOT 1.07
- CARM N/A
- Revenue
- SDOT $726,598,000.00
- CARM $19,964,000.00
- Revenue This Year
- SDOT $12.76
- CARM N/A
- Revenue Next Year
- SDOT $5.54
- CARM N/A
- P/E Ratio
- SDOT $1.30
- CARM N/A
- Revenue Growth
- SDOT 18.91
- CARM 32.45
- 52 Week Low
- SDOT $1.12
- CARM $0.14
- 52 Week High
- SDOT $7.00
- CARM $1.90
- Technical
- Relative Strength Index (RSI)
- SDOT 53.10
- CARM 52.02
- Support Level
- SDOT $1.33
- CARM $0.41
- Resistance Level
- SDOT $1.24
- CARM $0.56
- Average True Range (ATR)
- SDOT 0.21
- CARM 0.13
- MACD
- SDOT 0.02
- CARM -0.01
- Stochastic Oscillator
- SDOT 41.76
- CARM 20.33
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.